Recent studies using patient serum samples collected prior to the diagnosis of SLE have shown that this increase in IFNγ occurs coincident with the appearance of autoantibodies and prior to the development of clinical symptoms (73). This evidence concerns the gene IFNG and systemic lupus erythematosus.